PATENT CLAIM ANALYSIS

Application Number: 15754414
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "416000"]

Abstract:
The present invention relates to pharmaceutical compositions comprising the active substance Lenalidomide in one of the modifications selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide cocrystal or mixtures thereof, wherein the Lenalidomide particles have a particle size distribution (d 90 ) ranging from 1 μm to 100 μm.

Claim (Index 14):
An oral solid pharmaceutical composition comprising\n a. from 1.0% to 50.0% by weight, calculated on the basis of Lenalidomide base, of particles of a Lenalidomide modification being selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide cocrystal or mixtures thereof; b. from 50.0% to 99.0% by weight of one or more filler(s); and c. optionally comprising one or more disintegrant(s), lubricant(s); binder(s), glidant(s) and other pharmaceutically acceptable excipients; all % by weight-values being calculated relative to the total weight of the composition; wherein the particle size distribution (d 90 ) of the Lenalidomide particles is in the range of from 11 \u03bcm to 100 \u03bcm.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.31707
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14780495', '15852125', '11776012', '15387317', '13736699']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7122504552536126
- 35 USC 102 Novelty (BERT): 0.4969377787486066
- Combined Prediction Score: 0.690719187603112
- Mean Citation Score: 200.706194
- Max Citation Score: 204.72156
- Similarity Product: 142.7462826728439

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test